Stan Watowich

Founder & Chief Executive Officer Ridgeline Therapeutics GmbH

Seminars

Thursday 29th January 2026
Targeting Sarcopenia: The Fight Against Muscle Wasting in Aging & Chronic Disease
9:30 am
  • Understanding the biological drivers of sarcopenia in aging and chronic disease including muscle atrophy
  • Designing clinical trials with muscle strength and mobility as primary outcomes to assess patient quality of life
  • Exploring anabolic, hormonal, and regenerative approaches to restore muscle mass
Stan Watowich, speaking at 6th Age-Related Disease Therapeutics Summit